Incidence of sudden cardiac death after ventricular fibrillation complicating acute myocardial infarction: a 5-year cause-of-death analysis of the FAST-MI 2005 registry

Abstract

Patients developing VF in the setting of acute MI are at higher risk of in-hospital mortality. However, VF is not associated with a higher long-term all-cause or sudden cardiac death mortality.

Predictors of Ventricular Fibrillation at Reperfusion in Patients With Acute ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention

“…In-hospital mortality in rVF group was five times as high as in No rVF group as earlier reported by others (2,6,24). The majority of cases of in-hospital death in both rVF and No rVF groups were due to heart failure, among other causes were mechanical complications, cerebral injury and reinfarction, that is in accordance with a literature (1).…”

“…Because of its relatively low incidence, the predictors and prognostic value of VF at reperfusion are usually analysed together with other VF episodes at any time of acute STEMI (2)(3)(4). Some studies divided VF on early and late (2,5), some of them dealt with prereperfusion (6), periprocedural (1) or postprocedural (7) VF. While experimental studies have been searching for specific underlying mechanisms of reperfusional arrhythmias on cellular level, clinical studies focused on VF at reperfusion for STEMI in unselected populations, to the best of our knowledge, are lacking.…”

Survival after alcohol septal ablation versus conservative therapy in obstructive hypertrophic cardiomyopathy

“…No further lethal ventricular arrhythmia occurred in the three successfully resuscitated patients during follow-up suggested the prognostic significance of periprocedural cardiac arrest was limited, which agreed with the role of VF complicating acute MI [21,23,24]. Additionally, the numerically lower 1-year survival free from primary endpoint of ASA vs. conservative group (97.4% vs. 97.7%) was associated with mortality and aborted cardiac arrest occurred during the perioperative period in ASA group, whereas, in the conservative group, no in-hospital primary endpoint occurred.…”

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

“…występujące w ciągu pierwszych 48 h) wiąże się z nawet 5-krotnym wzrostem śmiertelności wewnątrzszpitalnej [277] i prawdopodobnie wskazuje również na zwiększone ryzyko zgonu w dłuższej obserwacji. Nie wszystkie z późniejszych zgonów są nagłe i decyzja o leczeniu za pomocą defibrylatora powinna uwzględniać występowanie dodatkowych czynników ryzyka poza VF lub VT w trakcie ACS [278,279].…”